PRTA
Price
$10.15
Change
-$0.21 (-2.03%)
Updated
Nov 19, 01:57 PM (EDT)
Capitalization
556.6M
85 days until earnings call
Intraday BUY SELL Signals
RCKT
Price
$2.95
Change
+$0.01 (+0.34%)
Updated
Nov 19, 01:57 PM (EDT)
Capitalization
317.63M
103 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PRTA vs RCKT

Header iconPRTA vs RCKT Comparison
Open Charts PRTA vs RCKTBanner chart's image
Prothena
Price$10.15
Change-$0.21 (-2.03%)
Volume$100
Capitalization556.6M
Rocket Pharmaceuticals
Price$2.95
Change+$0.01 (+0.34%)
Volume$17.33K
Capitalization317.63M
PRTA vs RCKT Comparison Chart in %
PRTA
Daily Signal:
Gain/Loss:
RCKT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PRTA vs. RCKT commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRTA is a Hold and RCKT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (PRTA: $10.34 vs. RCKT: $2.93)
Brand notoriety: PRTA and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRTA: 65% vs. RCKT: 134%
Market capitalization -- PRTA: $556.6M vs. RCKT: $317.63M
PRTA [@Biotechnology] is valued at $556.6M. RCKT’s [@Biotechnology] market capitalization is $317.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRTA’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 1 green FA rating(s).

  • PRTA’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 1 green, 4 red.
According to our system of comparison, RCKT is a better buy in the long-term than PRTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRTA’s TA Score shows that 6 TA indicator(s) are bullish while RCKT’s TA Score has 4 bullish TA indicator(s).

  • PRTA’s TA Score: 6 bullish, 3 bearish.
  • RCKT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, PRTA is a better buy in the short-term than RCKT.

Price Growth

PRTA (@Biotechnology) experienced а -1.34% price change this week, while RCKT (@Biotechnology) price change was -9.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.27%. For the same industry, the average monthly price growth was -5.78%, and the average quarterly price growth was +64.74%.

Reported Earning Dates

PRTA is expected to report earnings on Feb 12, 2026.

RCKT is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (-2.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRTA($557M) has a higher market cap than RCKT($318M). PRTA YTD gains are higher at: -25.343 vs. RCKT (-76.651). RCKT (-245.09M) and PRTA (-248.1M) have comparable annual earnings (EBITDA) . PRTA has more cash in the bank: 371M vs. RCKT (271M). PRTA has less debt than RCKT: PRTA (9.78M) vs RCKT (25.2M). PRTA has higher revenues than RCKT: PRTA (10.3M) vs RCKT (0).
PRTARCKTPRTA / RCKT
Capitalization557M318M175%
EBITDA-248.1M-245.09M101%
Gain YTD-25.343-76.65133%
P/E RatioN/AN/A-
Revenue10.3M0-
Total Cash371M271M137%
Total Debt9.78M25.2M39%
FUNDAMENTALS RATINGS
PRTA vs RCKT: Fundamental Ratings
PRTA
RCKT
OUTLOOK RATING
1..100
7753
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
12
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9697
PRICE GROWTH RATING
1..100
4565
P/E GROWTH RATING
1..100
92100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCKT's Valuation (12) in the Biotechnology industry is somewhat better than the same rating for PRTA (68). This means that RCKT’s stock grew somewhat faster than PRTA’s over the last 12 months.

RCKT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PRTA (100). This means that RCKT’s stock grew similarly to PRTA’s over the last 12 months.

PRTA's SMR Rating (96) in the Biotechnology industry is in the same range as RCKT (97). This means that PRTA’s stock grew similarly to RCKT’s over the last 12 months.

PRTA's Price Growth Rating (45) in the Biotechnology industry is in the same range as RCKT (65). This means that PRTA’s stock grew similarly to RCKT’s over the last 12 months.

PRTA's P/E Growth Rating (92) in the Biotechnology industry is in the same range as RCKT (100). This means that PRTA’s stock grew similarly to RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PRTARCKT
RSI
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
PRTA
Daily Signal:
Gain/Loss:
RCKT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGELX98.95N/A
N/A
Vanguard Energy Adm
HOOCX27.94N/A
N/A
Hartford Schroders US Small Cap Opps C
RYFNX91.02N/A
N/A
Rydex Financial Services A
GLCCX23.20N/A
N/A
Goldman Sachs Large Cap Gr Insghts C
MSGNX6.74N/A
N/A
MassMutual Small Cap Gr Eq R3

PRTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRTA has been loosely correlated with RCKT. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTA
1D Price
Change %
PRTA100%
+0.88%
RCKT - PRTA
53%
Loosely correlated
-3.45%
SVRA - PRTA
47%
Loosely correlated
-0.71%
DNLI - PRTA
38%
Loosely correlated
+0.58%
OCUL - PRTA
38%
Loosely correlated
-1.09%
AXON - PRTA
38%
Loosely correlated
-1.74%
More

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with SVRA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then SVRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
-3.45%
SVRA - RCKT
59%
Loosely correlated
-0.71%
PRTA - RCKT
53%
Loosely correlated
+0.88%
AXON - RCKT
52%
Loosely correlated
-1.74%
VCYT - RCKT
47%
Loosely correlated
-1.35%
RGNX - RCKT
43%
Loosely correlated
+0.94%
More